课题基金 / 基金详情

Mechanochemical regulation of endothelial permeability

Mechanochemical regulation of endothelial permeability
内皮细胞通透性的机械化学调节
批准号:
7109286
负责人:
Konstantin Birukov
金额:
$33.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-16 至 2008-06-30

项目摘要

项目成果

Konstantin Birukov的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):肺内皮是一种关键的半选择性细胞屏障,可防止水、溶质、大分子和细胞从血管系统中渗漏。由高潮气量机械通气引起的肺内皮细胞(EC)屏障完整性受损与EC经历的循环拉伸模式改变相关,并导致通透性增加、肺泡泛洪、白细胞浸润、低氧血症以及发病率和死亡率增加。我们以前已经确定了由屏障保护剂(1-磷酸鞘氨醇)和屏障破坏剂(凝血酶)引起的EC通透性变化的细胞骨架机制,并描述了小GTP酶Rac和Rho在与EC屏障调节相关的细胞灶性粘附和粘附连接的重塑中的重要参与。我们发表的结果和初步数据强烈表明,机械刺激的Rac和Rho活动的调制显着影响激动剂诱导的EC通透性调节。我们最初的假设是,Rac和Rho GTP酶的幅度依赖性调节周期性拉伸(CS)可能决定肺EC屏障功能障碍的严重程度和屏障恢复率在机械通气在高潮气量。我们还假设,细胞骨架(肌动蛋白,core-lin),粘着斑(桩蛋白,PKL/GIT 2),和粘附连接(VE-钙粘蛋白,β-连环蛋白)的小GTP酶的效应器的相互作用可能是关键参与肺屏障的调节机械力。具体目标#1将使用体外和体内方法的组合确定肺EC经历的CS的生理和病理相关水平,并将探索幅度依赖性Rac和Rho调节与EC细胞骨架变化之间的联系。具体目标#2将研究生理和病理CS水平在激动剂诱导的EC细胞骨架、细胞接触和单层完整性调节中的作用。具体目标#3将确定Rac和Rho特异性GEF(Tiam 1、Vav 2、betaPIX、GEF-H1和p115-RhoGEF)对小GT酶活性进行机械化学调节的分子机制。我们推测,本研究中获得的结果将显著影响我们对小GTP酶在EC通过涉及细胞骨架和细胞粘附重塑的特定机制适应机械化学环境改变中的作用的理解(SA#1和SA#2),发现了通过机械化学刺激的GEF介导的Rac和Rho调节的新机制(SA#3),并使我们对呼吸机诱导的肺损伤中内皮功能障碍的细胞机制有了新的认识。
英文摘要
DESCRIPTION (provided by applicant): Pulmonary endothelium is a critical, semi-selective cellular barrier, which prevents the leakage of water, solutes, macromolecules and cells from the vasculature. Compromised pulmonary endothelial cell (EC) barrier integrity caused by mechanical ventilation at high tidal volumes is associated with altered patterns of cyclic stretch experienced by EC, and leads to increased permeability, alveolar flooding, leukocyte infiltration, hypoxemia, and increased morbidity and mortality. We have previously identified cytoskeletal mechanisms of EC permeability changes caused by barrier-protective (sphingosine 1-phosphate) and barrier-disruptive (thrombin) agents and described a critical involvement of small GTPases Rac and Rho in remodeling of cell focal adhesions and adherens junctions associated with EC barrier regulation. Our published results and preliminary data strongly suggest, that modulation of Rac and Rho activities by mechanical stimuli significantly impacts agonist-induced regulation of EC permeability. Our original hypothesis is that magnitude-dependent regulation of Rac and Rho GTPases by cyclic stretch (CS) may determine severity of the pulmonary EC barrier dysfunction and rates of barrier restoration during mechanical ventilation at high tidal volume. We also hypothesize that interactions of cytoskeletal (actin, cortactin), focal adhesion (paxillin, PKL/GIT2), and adherens junction (VE-cadherin, beta-catenin) effectors of small GTPases may be critically involved in the lung barrier regulation by mechanical forces. Specific Aim #1 will determine physiological and pathologically relevant levels of CS experienced by pulmonary EC using combination of in vitro and in vivo approaches and will explore a link between magnitude-dependent Rac and Rho regulation and EC cytoskeletal changes. Specific Aim #2 will investigate a role of physiological and pathological CS levels in the agonist-induced regulation of EC cytoskeleton, cell contacts, and monolayer integrity. Specific Aim #3 will identify molecular mechanisms of mechanochemical regulation of small GTPase activities by Rac- and Rho-specific GEFs (Tiam1, Vav2, betaPIX, GEF-H1 and p115-RhoGEF). We speculate that the results obtained in this study will significantly impact our understanding of the role of small GTPases in the EC adaptation to alterations of mechanochemical environment via specific mechanisms involving cytoskeletal and cell adhesion remodeling (SA#1 and SA#2), discover novel mechanisms of GEF-mediated regulation of Rac and Rho by mechanochemical stimuli (SA#3), and allow us to develop new insights into cellular mechanisms underlying endothelial dysfunction in ventilator-induced lung injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of inflammation in aging lung
  • 批准号:
    9901002
  • 项目类别:
  • 资助金额:
    $38.36万
  • 财政年份:
    2020
  • 负责人:
    Konstantin Birukov
  • 依托单位:
Modulation of inflammation in aging lung
  • 批准号:
    10112958
  • 项目类别:
  • 资助金额:
    $38.36万
  • 财政年份:
    2020
  • 负责人:
    Konstantin Birukov
  • 依托单位:
Modulation of inflammation in aging lung
  • 批准号:
    10329996
  • 项目类别:
  • 资助金额:
    $38.43万
  • 财政年份:
    2020
  • 负责人:
    Konstantin Birukov
  • 依托单位:
Modulation of inflammation in aging lung
  • 批准号:
    10557197
  • 项目类别:
  • 资助金额:
    $38.46万
  • 财政年份:
    2020
  • 负责人:
    Konstantin Birukov
  • 依托单位:
海外基金